申请人:SMITHKLINE BECKMAN CORPORATION
公开号:EP0195673A2
公开(公告)日:1986-09-24
Certain new vasopressin-like peptides which have structures characterized by having a bisaminoalkylbenzene present in the vasopressin tail at the 7- or 8-position retain vasopressin antagonist activity. A species of the invention is [1-β-mercapto-β,β-cyclopentamethylenepropionic acid)-2-(O-ethyl)-D-tyrosine-4-valine-8-1',4'-bis(aminomethyl)-benzene-9-desglycinamide]vasopressin.
某些新的血管加压素样肽,其结构特征是在血管加压素尾部的 7-或 8-位上有一个双氨基烷基苯,保持血管加压素拮抗剂的活性。 本发明的一个品种是[1-β-巯基-β,β-环戊基亚甲基丙酸)-2-(O-乙基)-D-酪氨酸-4-缬氨酸-8-1',4'-双(氨基甲基)-苯-9-去甘氨酰胺]血管加压素。